Beck Bode LLC’s CureVac CVAC Stock Holding History

Beck Bode LLC’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-80	Closed	-$6K	–	135
2021 Q2	$6K	Buy	+80	New	+$8K	﹤0.01%	254

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Beck Bode LLC's CVAC Position: Q3 2021 in Review

Beck Bode LLC sold out of CureVac (CVAC) in Q3 2021, closing a stake of 80 shares — an estimated $6K sold.

Beck Bode LLC first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 112 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Beck Bode LLC reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 80 CureVac shares in Q3 2021, an estimated $6K.
Beck Bode LLC first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
Beck Bode LLC's CureVac position peaked at $6K in Q2 2021.
112 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.